Ameera Patel couldn’t get diagnosed with her own asthma. So she built this device and raised $19M
TidalSense is a respiratory technology company headquartered in Cambridge, UK, building AI-driven diagnostic and monitoring technologies for COPD and asthma. The company is transforming COPD diagnostic pathways to drive efficiency and drastically improve patient care through purposeful innovation grounded in cutting-edge science. Its mission is to become a global leader in respiratory diagnostics and care management. The N-Tidal® platform delivers rapid, accurate point-of-care diagnostics and remote patient monitoring solutions powered by digital biomarkers and exponentially powerful AI.